- HOOKIPA Pharma press release ( NASDAQ: HOOK ): Q3 GAAP EPS of -$0.25 beats by $0.02 .
- Revenue of $2.23M (-42.4% Y/Y) misses by $0.68M .
For further details see:
HOOKIPA Pharma GAAP EPS of -$0.25 beats by $0.02, revenue of $2.23M misses by $0.68MFor further details see:
HOOKIPA Pharma GAAP EPS of -$0.25 beats by $0.02, revenue of $2.23M misses by $0.68MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer Company is conducting a review of its business operations and strategy to determine best path to create shareholder value and realize the full potential...
A look at the top 10 most actives in the United States Longeveron Inc. (LGVN) rose 69.0% to $4.8499 on volume of 46,980,986 shares Virpax Pharmaceuticals Inc. (VRPX) rose 161.5% to $3.0333 on volume of 46,199,502 shares Maxeon Solar Technologies Ltd. (MAXN) fell 0.6% to $0.2464 on volume ...
2024-07-09 09:02:05 ET Hookipa Pharma Inc (HOOK) announced stock split at a ratio of 1-for-10 on 2024-07-10 ... Full story available on KlickAnalytics.com